login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
PROPHASE LABS INC (PRPH) Stock News
USA
- NASDAQ:PRPH -
US74345W1080
-
Common Stock
0.4335
USD
-0.08 (-15.84%)
Last: 9/12/2025, 8:09:24 PM
0.4522
USD
+0.02 (+4.31%)
After Hours:
9/12/2025, 8:09:24 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
PRPH Latest News, Press Relases and Analysis
All
Press Releases
18 hours ago - By: Benzinga
- Mentions:
COSM
ADXN
ISPC
HCWB
...
12 Health Care Stocks Moving In Friday's Intraday Session
a day ago - By: ProPhase Labs, Inc.
ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor
2 days ago - By: Benzinga
- Mentions:
GRI
GLMD
COSM
MODD
...
12 Health Care Stocks Moving In Thursday's After-Market Session
25 days ago - By: ProPhase Labs, Inc.
ProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of Shareholders
a month ago - By: The Motley Fool
ProPhase Labs Posts Narrower Q2 Loss
a month ago - By: Zacks Investment Research
- Mentions:
DERM
Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates
a month ago - By: ProPhase Labs, Inc.
ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025
a month ago - By: Zacks Investment Research
- Mentions:
IRWD
Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates
a month ago - By: Zacks Investment Research
- Mentions:
ZTS
Zoetis (ZTS) Q2 Earnings and Revenues Surpass Estimates
2 months ago - By: ProPhase Labs, Inc.
ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement
3 months ago - By: ProPhase Labs, Inc.
ProPhase Labs, Inc. Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule
3 months ago - By: ProPhase Labs, Inc.
ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smartâ„¢ Test in Detecting Esophageal Cancer
3 months ago - By: ProPhase Labs, Inc.
ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform
4 months ago - By: Zacks Investment Research
- Mentions:
VVOS
Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates
Please enable JavaScript to continue using this application.